Skip to content

Emergent BioSolutions Inc.

Public company
Headquarters
GAITHERSBURG, Maryland
Ticker
EBS
CIK
0001367644

WARN notices since 2024

3
First: May 2, 2024

Workers affected since 2024

274
Across 3 notices

Executive changes, last 12 months

4
2 appointments, 2 departures

Last event

Oct 16, 2026
Executive departureCFO departs: Richard Lindahl

Workers affected over time

Cumulative workers in WARN notices since 2024

0100200300Jan '24Jan '25Jan '26274

Leadership

Role and personSinceChange
CFORichard LindahlOct 16, 2026Departed
CFOFrank VargoOct 16, 2026Appointed
CMOSimon LowryAug 5, 2026Departed
Executive Vice President, Chief Growth OfficerStephanie DuatschekAug 5, 2026Appointed

Related companies

Same industry and state, with recent events.

  1. Executive departure

    CFO departs: Richard Lindahl

    Richard Lindahl, Chief Financial Officer of Emergent BioSolutions Inc., departs the role, effective December 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Financial Officer

    Source: SEC 8-K, filed Oct 16, 2026

  2. Executive appointment

    CFO appointed: Frank Vargo

    Frank Vargo was named Interim Chief Financial Officer of Emergent BioSolutions Inc., effective January 1, 2027. Frank Vargo succeeds Richard Lindahl. The company reported the change in an 8-K that cites Item 5.02.

    Role: Interim Chief Financial Officer

    Source: SEC 8-K, filed Oct 16, 2026

  3. Executive departure

    CMO departs: Simon Lowry

    Simon Lowry, Chief Medical Officer, Head of Research and Development of Emergent BioSolutions Inc., departs the role, effective August 19, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Medical Officer, Head of Research and Development

    Source: SEC 8-K, filed Aug 5, 2026

  4. Executive appointment

    Executive Vice President, Chief Growth Officer appointed: Stephanie Duatschek

    Stephanie Duatschek was named Executive Vice President, Chief Growth Officer of Emergent BioSolutions Inc.. The company reported the change in an 8-K that cites Item 5.02.

    Role: Executive Vice President, Chief Growth Officer

    Source: SEC 8-K, filed Aug 5, 2026

  5. layoffs from Oct 4, 2026

    WARN notice

    WARN notice: Gaithersburg, MD

    Emergent Biosolutions, Inc. filed a WARN notice with the Maryland WARN list on Aug 5, 2026 covering 34 workers at 300 Professional Drive, Gaithersburg, MD 20879. The layoffs take effect on Oct 4, 2026.

    Site: Gaithersburg, MD

    Workers affected: 34

    Source: Maryland WARN list, filed Aug 5, 2026

  6. layoffs from Aug 2, 2024

    Plant closure

    Plant closure: Rockville, MD

    Emergent Biosolutions, Inc. filed a WARN notice with the Maryland WARN list on May 16, 2024 covering 86 workers at 9920 Medical Center Drive Rockville, MD 20850. The site closes on Aug 2, 2024.

    Site: Rockville, MD

    Workers affected: 86

    Source: Maryland WARN list, filed May 16, 2024

  7. layoffs from Jul 1, 2024

    WARN notice

    WARN notice: Gaithersburg, MD

    Emergent Biosolutions, Inc. filed a WARN notice with the Maryland WARN list on May 2, 2024 covering 154 workers at 300 Professional Drive Gaithersburg, MD 20879. The layoffs take effect on Jul 1, 2024.

    Site: Gaithersburg, MD

    Workers affected: 154

    Source: Maryland WARN list, filed May 2, 2024

  8. layoffs from Oct 7, 2023

    WARN notice

    WARN notice: Baltimore, MD

    Emergent Biosolutions, Inc. filed a WARN notice with the Maryland WARN list on Aug 8, 2023 covering 211 workers at 5901 E. Lombard St. Baltimore, MD 21224. The layoffs take effect on Oct 7, 2023.

    Site: Baltimore, MD

    Workers affected: 211

    Source: Maryland WARN list, filed Aug 8, 2023

Last verified Nov 8, 2026